These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10453727)

  • 1. Enhancement of cisplatin cytotoxicity by terbium in cisplatin-resistant MDA/CH human breast cancer cells.
    Fuller TL; Canada RG
    Cancer Chemother Pharmacol; 1999; 44(3):249-52. PubMed ID: 10453727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of terbium on the cellular accumulation of cisplatin in MDA-MB-231 human breast tumor cells.
    Mack KM; Canada RG; Andrews PA
    Cancer Chemother Pharmacol; 1997; 39(3):217-22. PubMed ID: 8996523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of terbium on the cytotoxicity of cisplatin in FaDu human head and neck squamous cell carcinoma.
    Paltoo DN; Canada RG
    Cancer Biochem Biophys; 1998 Oct; 16(3):213-27. PubMed ID: 10072206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of terbium on the accumulation of cisplatin in human ovarian cancer cells.
    Canada RG; Andrews PA; Mack KM; Haider A
    Biochim Biophys Acta; 1995 May; 1267(1):25-30. PubMed ID: 7779865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding of terbium and cisplatin to C13* human ovarian cancer cells using time-resolved terbium luminescence.
    Canada RG; Paltoo DN
    Biochim Biophys Acta; 1998 Nov; 1448(1):85-98. PubMed ID: 9824675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic anti-cancer effects of silibinin with conventional cytotoxic agents doxorubicin, cisplatin and carboplatin against human breast carcinoma MCF-7 and MDA-MB468 cells.
    Tyagi AK; Agarwal C; Chan DC; Agarwal R
    Oncol Rep; 2004 Feb; 11(2):493-9. PubMed ID: 14719089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of tumor cell transforming growth factor-betas enhances cell cycle progression and sensitizes human breast carcinoma cells to cytotoxic chemotherapy.
    Ohmori T; Yang JL; Price JO; Arteaga CL
    Exp Cell Res; 1998 Dec; 245(2):350-9. PubMed ID: 9851876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerivastatin demonstrates enhanced antitumor activity against human breast cancer cell lines when used in combination with doxorubicin or cisplatin.
    Kozar K; Kaminski R; Legat M; Kopec M; Nowis D; Skierski JS; Koronkiewicz M; Jakóbisiak M; Golab J
    Int J Oncol; 2004 May; 24(5):1149-57. PubMed ID: 15067336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
    Arisan ED; Kutuk O; Tezil T; Bodur C; Telci D; Basaga H
    Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collateral sensitivity to novel thymidylate synthase inhibitors correlates with folate cycle enzymes impairment in cisplatin-resistant human ovarian cancer cells.
    Marverti G; Ligabue A; Paglietti G; Corona P; Piras S; Vitale G; Guerrieri D; Luciani R; Costi MP; Frassineti C; Moruzzi MS
    Eur J Pharmacol; 2009 Aug; 615(1-3):17-26. PubMed ID: 19446547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity to camptothecin of human breast carcinoma and normal endothelial cells.
    Jones CB; Clements MK; Wasi S; Daoud SS
    Cancer Chemother Pharmacol; 1997; 40(6):475-83. PubMed ID: 9332461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
    Mizutani Y; Nakao M; Ogawa O; Yoshida O; Bonavida B; Miki T
    J Urol; 2001 Jan; 165(1):263-70. PubMed ID: 11125422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF; Koberle B; Masters JR; Kelland LR
    Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin E succinate (VES) induces Fas sensitivity in human breast cancer cells: role for Mr 43,000 Fas in VES-triggered apoptosis.
    Yu W; Israel K; Liao QY; Aldaz CM; Sanders BG; Kline K
    Cancer Res; 1999 Feb; 59(4):953-61. PubMed ID: 10029090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
    Foroodi F; Duivenvoorden WC; Singh G
    Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3n-6) enhances docetaxel (Taxotere) cytotoxicity in human breast carcinoma cells: Relationship to lipid peroxidation and HER-2/neu expression.
    Menendez JA; Ropero S; Lupu R; Colomer R
    Oncol Rep; 2004 Jun; 11(6):1241-52. PubMed ID: 15138562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of Fatty Acid Synthase (FASN) synergistically enhances the efficacy of 5-fluorouracil in breast carcinoma cells.
    Vazquez-Martin A; Ropero S; Brunet J; Colomer R; Menendez JA
    Oncol Rep; 2007 Oct; 18(4):973-80. PubMed ID: 17786362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemosensitization of human prostate carcinoma cell lines to anti-fas-mediated cytotoxicity and apoptosis.
    Uslu R; Borsellino N; Frost P; Gárban H; Ng CP; Mizutani Y; Belldegrun A; Bonavida B
    Clin Cancer Res; 1997 Jun; 3(6):963-72. PubMed ID: 9815772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
    Lai SL; Hwang J; Perng RP; Whang-Peng J
    Oncol Res; 1995; 7(1):31-8. PubMed ID: 7549042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.